Hosted on MSN
China’s Jiangsu Aidea eyes Hong Kong listing as gateway to US and European AIDS markets
Yangzhou-based drug maker views Hong Kong as a 'good window' for its international expansion in HIV and Aids treatments Jiangsu Aidea Pharmaceutical, which develops anti-HIV and Aids treatments, plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results